# Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment

> **NCT00789022** · — · UNKNOWN · sponsor: **Shalvata Mental Health Center** · enrollment: 80 (estimated)

## Conditions studied

- Schizophrenia
- Schizophreniform
- Schizoaffective Disorder
- Brief Psychotic Episode

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00789022
- **Lead sponsor:** Shalvata Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789022, "Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00789022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*